T cell epitope mapping of secukinumab and ixekizumab in healthy donors
2020
ABSTRACTSecukinumab, a human monoclonal antibody that selectively neutralizes IL-17A, has consistently shown low anti-drug antibody responses in patients with psoriasis, psoriatic arthritis, and an...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
10
Citations
NaN
KQI